Quadrant Capital Group’s 1Life Healthcare ONEM Stock Holding History

Quadrant Capital Group’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-378	Closed	-$6.32K	–	2836
2022 Q4	$6.32K	Buy	378 +17	+5%	+$287	﹤0.01%	2141
2022 Q3	$6K	Hold	361	–	–	﹤0.01%	2115
2022 Q2	$3K	Buy	361 +349	+2,908%	+$3K	﹤0.01%	2168
2022 Q1	$0	Sell	12 -46	-79%	-$515	﹤0.01%	2763
2021 Q4	$1K	Buy	+58	New	+$1.13K	﹤0.01%	2460

Quadrant Capital Group's ONEM Position: Q1 2023 in Review

Quadrant Capital Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 378 shares — an estimated $6.32K sold.

Quadrant Capital Group first reported a position in ONEM in Q4 2021 and held it in 5 quarters. The position peaked at $6.32K in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Quadrant Capital Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Quadrant Capital Group sold 378 1Life Healthcare shares in Q1 2023, an estimated $6.32K.
Quadrant Capital Group first reported a position in 1Life Healthcare in Q4 2021 and held it in 5 quarters.
Quadrant Capital Group's 1Life Healthcare position peaked at $6.32K in Q4 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Quadrant Capital Group's 13F filing for Q1 2023, filed 11 May 2023.